Roisman LC - Search Results

1

The EU-funded I³LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.

Prelaj A, Ganzinelli M, Trovo' F, Roisman LC, Pedrocchi ALG, Kosta S, Restelli M, Ambrosini E, Broggini M, Pravettoni G, Monzani D, Nuara A, Amat R, Spathas N, Willis M, Pearson A, Dolezal J, Mazzeo L, Sangaletti S, Correa AM, Aguaron A, Watermann I, Popa C, Raimondi G, Triulzi T, Steurer S, Lo Russo G, Linardou H, Peled N, Felip E, Reck M, Garassino MC. Prelaj A, et al. Among authors: roisman lc. Clin Lung Cancer. 2023 Jun;24(4):381-387. doi: 10.1016/j.cllc.2023.02.005. Epub 2023 Feb 28. Clin Lung Cancer. 2023. PMID: 36959048

2

Liquid biopsy in the practice of neo-oncology.

Geva S, Roisman LC, Peled N. Geva S, et al. Among authors: roisman lc. J Thorac Dis. 2016 Oct;8(10):E1279-E1281. doi: 10.21037/jtd.2016.10.72. J Thorac Dis. 2016. PMID: 27867607 Free PMC article. No abstract available.

3

The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer.

Laufer-Geva S, Rozenblum AB, Twito T, Grinberg R, Dvir A, Soussan-Gutman L, Ilouze M, Roisman LC, Dudnik E, Zer A, Rotem O, Lanman RB, Peled N. Laufer-Geva S, et al. Among authors: roisman lc. J Thorac Oncol. 2018 Nov;13(11):1705-1716. doi: 10.1016/j.jtho.2018.07.101. Epub 2018 Aug 16. J Thorac Oncol. 2018. PMID: 30121392 Free article.

4

Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi).

Dudnik E, Bshara E, Grubstein A, Fridel L, Shochat T, Roisman LC, Ilouze M, Rozenblum AB, Geva S, Zer A, Rotem O, Allen AM, Peled N. Dudnik E, et al. Among authors: roisman lc. Lung Cancer. 2018 Oct;124:117-124. doi: 10.1016/j.lungcan.2018.07.044. Epub 2018 Aug 3. Lung Cancer. 2018. PMID: 30268448

5

Two are better than one on progression through MET mechanism for EGFR+ NSCLC patients.

Kian W, Roisman LC, Peled N. Kian W, et al. Among authors: roisman lc. Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S334-S335. doi: 10.21037/tlcr.2018.12.01. Transl Lung Cancer Res. 2018. PMID: 30705848 Free PMC article. No abstract available.

6

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.

Dudnik E, Bar J, Peled N, Bshara E, Kuznetsov T, Cohen AY, Shochat T, Nechushtan H, Onn A, Agbarya A, Moskovitz M, Keren S, Popovits-Hadar N, Urban D, Mishaeli M, Rabinovich NM, Brenner R, Zer A, Rotem O, Roisman LC, Wollner M; Israel Lung Cancer Group. Dudnik E, et al. Among authors: roisman lc. Clin Lung Cancer. 2019 Jul;20(4):278-286.e1. doi: 10.1016/j.cllc.2019.03.007. Epub 2019 Apr 5. Clin Lung Cancer. 2019. PMID: 31060855

7

Nivolumab Induced Hepatocanalicular Cholestasis and Liver Rejection in a Patient With Lung Cancer and Liver Transplant.

Braun M, Fuchs V, Kian W, Roisman L, Peled N, Rosenberg E, Friedel L. Braun M, et al. J Thorac Oncol. 2020 Sep;15(9):e149-e150. doi: 10.1016/j.jtho.2020.01.026. J Thorac Oncol. 2020. PMID: 32854914 Free article. No abstract available.

8

The impact of osimertinib' line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance.

Fuchs V, Roisman L, Kian W, Daniel L, Dudnik J, Nechushtan H, Goldstein I, Dvir A, Soussan-Gutman L, Grinberg R, Gillis R, Peled N. Fuchs V, et al. Lung Cancer. 2021 Mar;153:126-133. doi: 10.1016/j.lungcan.2020.12.039. Epub 2021 Jan 14. Lung Cancer. 2021. PMID: 33486418

9

Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients.

Fuchs V, Kian W, Lichtenberg R, Cooper JM, Remilah AA, Levin D, Peled N, Roisman LC. Fuchs V, et al. Among authors: roisman lc. Clin Drug Investig. 2022 Feb;42(2):185-192. doi: 10.1007/s40261-021-01116-4. Epub 2022 Jan 19. Clin Drug Investig. 2022. PMID: 35044639

10

Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.

Roisman LC, Kian W, Anoze A, Fuchs V, Spector M, Steiner R, Kassel L, Rechnitzer G, Fried I, Peled N, Bogot NR. Roisman LC, et al. NPJ Precis Oncol. 2023 Nov 21;7(1):125. doi: 10.1038/s41698-023-00473-x. NPJ Precis Oncol. 2023. PMID: 37990050 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page